Stauffer Fausto, De Miranda Joari, Schechter Marcos C, Carneiro Fabiana A, Salgado Leonardo T, Machado Gisele F, Da Poian Andrea T
Instituto de Bioquímica Médica, Programa de Biologia Molecular e Biotecnologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-590, Brazil.
Antiviral Res. 2007 Jan;73(1):31-9. doi: 10.1016/j.antiviral.2006.07.007. Epub 2006 Aug 2.
Membrane fusion is an essential step in the entry of enveloped viruses into their host cells triggered by conformational changes in viral glycoproteins. We have demonstrated previously that modification of vesicular stomatitis virus (VSV) with diethylpyrocarbonate (DEPC) abolished conformational changes on VSV glycoprotein and the fusion reaction catalyzed by the virus. In the present study, we evaluated whether treatment with DEPC was able to inactivate the virus. Infectivity and viral replication were abolished by viral treatment with 0.5mM DEPC. Mortality profile and inflammatory response in the central nervous system indicated that G protein modification with DEPC eliminates the ability of the virus to cause disease. In addition, DEPC treatment did not alter the conformational integrity of surface proteins of inactivated VSV as demonstrated by transmission electron microscopy and competitive ELISA. Taken together, our results suggest a potential use of histidine (His) modification to the development of a new process of viral inactivation based on fusion inhibition.
膜融合是包膜病毒进入宿主细胞的关键步骤,由病毒糖蛋白的构象变化引发。我们之前已证明,用焦碳酸二乙酯(DEPC)修饰水泡性口炎病毒(VSV)可消除VSV糖蛋白的构象变化以及该病毒催化的融合反应。在本研究中,我们评估了DEPC处理是否能够使病毒失活。用0.5mM DEPC处理病毒可消除其感染性和病毒复制。中枢神经系统的死亡率曲线和炎症反应表明,用DEPC修饰G蛋白可消除病毒致病能力。此外,如透射电子显微镜和竞争性ELISA所示,DEPC处理并未改变灭活VSV表面蛋白的构象完整性。综上所述,我们的结果表明组氨酸(His)修饰在基于融合抑制开发新的病毒灭活方法方面具有潜在用途。